BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors - Yahoo! Finance -BoardProspects

BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors

Yahoo! Finance Jul 5 2022 BoardMoves

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the appointment of Michael P. Miller to its Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- A New Diversity Monitor for the S.E.C. - NYTimes.com also categorized in BoardMoves
- Thompson Joins Microsoft Board also categorized in BoardMoves
- Boeing CFO Joins JPMorgan Board also categorized in BoardMoves
- KKR representatives resign from Kodak's board also categorized in BoardMoves
- New CEO and Board Research from Stanford and The Miles Group: In Grading CEO Performance, Financials Still Dominate also published in Yahoo! Finance
- Qualcomm co-founder to retire from board in 2012 also categorized in BoardMoves
- Time Inc. Appoints Griffin CEO also categorized in BoardMoves
- The Horace Mann Companies on Forbes Top 100 Trustworthy Companies in America also published in Yahoo! Finance
- NASDAQ OMX Reports Record Fourth Quarter 2013 Results also mentions Nasdaq
- Google Names VMware Cofounder Diane Greene To Its Board also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned